Apogee Therapeutics, Inc. - APGE
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Mar 27, 2026 | SCHEDULE 13D/A | — | 9.99% | — | View |
| Mar 26, 2026 | SCHEDULE 13G/A | The Vanguard Group | 0.0% | 0 | View |
| Mar 06, 2026 | SCHEDULE 13G | T. Rowe Price Investment Management, Inc. | 11.3% | 6,213,827 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | RTW Investments, LP | 4.9% | 2,712,097 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Roderick Wong | 4.9% | 2,712,097 | View |
| Feb 10, 2026 | SCHEDULE 13G/A | Wellington Management Group LLP | 8.7% | 4,746,585 | View |
| Feb 10, 2026 | SCHEDULE 13G/A | Wellington Group Holdings LLP | 8.7% | 4,746,585 | View |
| Feb 10, 2026 | SCHEDULE 13G/A | Wellington Investment Advisors Holdings LLP | 8.7% | 4,746,585 | View |
| Feb 10, 2026 | SCHEDULE 13G/A | Wellington Management Company LLP | 8.3% | 4,746,585 | View |
| Jan 30, 2026 | SCHEDULE 13G | The Vanguard Group | 5.21% | 2,857,824 | View |
| Jan 22, 2026 | SCHEDULE 13D/A | — | 9.99% | — | View |
| Nov 14, 2025 | SCHEDULE 13G/A | DRIEHAUS CAPITAL MANAGEMENT LLC | 4.68% | 2,158,502 | View |
| Oct 14, 2025 | SCHEDULE 13D/A | — | 9.99% | — | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.